Novo Nordisk’s Wegovy (injectable semaglutide) is currently the rage as a treatment option for obesity. But the question on the mind of many in markets like India is when supplies will be available in the country.
Wegovy In The Wings, Novo Outlines Potential, Sizes Up Perceptions In India
Novo Nordisk India MD talks to Scrip about what to expect when Wegovy arrives in India and the local trajectory of Rybelsus. The Danish group also shared findings of a study around obesity.
